269 related articles for article (PubMed ID: 21913276)
1. Ultrasound evaluation of intra-abdominal sites of disease to predict likelihood of suboptimal cytoreduction in advanced ovarian cancer: a prospective study.
Testa AC; Ludovisi M; Mascilini F; Di Legge A; Malaggese M; Fagotti A; Fanfani F; Salerno MG; Ercoli A; Scambia G; Ferrandina G
Ultrasound Obstet Gynecol; 2012 Jan; 39(1):99-105. PubMed ID: 21913276
[TBL] [Abstract][Full Text] [Related]
2. Hematogenous Splenic Metastases as an Independent Negative Prognosis Factor at the Moment of Primary Cytoreduction in Advanced Stage Epithelial Ovarian Cancer--A Single Center Experience.
Bacalbasa N; Balescu I; Dima S; Brasoveanu V; Popescu I
Anticancer Res; 2015 Oct; 35(10):5649-54. PubMed ID: 26408738
[TBL] [Abstract][Full Text] [Related]
3. Surgical outcome prediction in patients with advanced ovarian cancer using computed tomography scans and intraoperative findings.
Kim HJ; Choi CH; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Taiwan J Obstet Gynecol; 2014 Sep; 53(3):343-7. PubMed ID: 25286788
[TBL] [Abstract][Full Text] [Related]
4. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography.
Bristow RE; Duska LR; Lambrou NC; Fishman EK; O'Neill MJ; Trimble EL; Montz FJ
Cancer; 2000 Oct; 89(7):1532-40. PubMed ID: 11013368
[TBL] [Abstract][Full Text] [Related]
5. Imaging diagnostics in ovarian cancer: magnetic resonance imaging and a scoring system guiding choice of primary treatment.
Kasper SM; Dueholm M; Marinovskij E; Blaakær J
Eur J Obstet Gynecol Reprod Biol; 2017 Mar; 210():83-89. PubMed ID: 27984747
[TBL] [Abstract][Full Text] [Related]
6. Role of ultrasound in advanced peritoneal malignancies.
De Blasis I; Moruzzi MC; Moro F; Mascilini F; Cianci S; Gueli Alletti S; Turco LC; Garganese G; Scambia G; Testa AC
Minerva Med; 2019 Aug; 110(4):292-300. PubMed ID: 31081311
[TBL] [Abstract][Full Text] [Related]
7. Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial.
Ferrandina G; Sallustio G; Fagotti A; Vizzielli G; Paglia A; Cucci E; Margariti A; Aquilani L; Garganese G; Scambia G
Br J Cancer; 2009 Oct; 101(7):1066-73. PubMed ID: 19738608
[TBL] [Abstract][Full Text] [Related]
8. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.
Nelson BE; Rosenfield AT; Schwartz PE
J Clin Oncol; 1993 Jan; 11(1):166-72. PubMed ID: 8418230
[TBL] [Abstract][Full Text] [Related]
9. Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography--a prospective study.
Risum S; Høgdall C; Loft A; Berthelsen AK; Høgdall E; Nedergaard L; Lundvall L; Engelholm SA
Gynecol Oncol; 2008 Feb; 108(2):265-70. PubMed ID: 18055006
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic accuracy of hand-assisted laparoscopy in predicting resectability of peritoneal carcinomatosis from gynecological malignancies.
Varnoux C; Huchon C; Bats AS; Bensaid C; Achouri A; Nos C; Lécuru F
Eur J Surg Oncol; 2013 Jul; 39(7):774-9. PubMed ID: 23597496
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of MDCT in the preoperative definition of Peritoneal Cancer Index (PCI) in patients with advanced ovarian cancer who underwent peritonectomy and hyperthermic intraperitoneal chemotherapy (HIPEC).
Mazzei MA; Khader L; Cirigliano A; Cioffi Squitieri N; Guerrini S; Forzoni B; Marrelli D; Roviello F; Mazzei FG; Volterrani L
Abdom Imaging; 2013 Dec; 38(6):1422-30. PubMed ID: 23744439
[TBL] [Abstract][Full Text] [Related]
12. A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer.
Suidan RS; Ramirez PT; Sarasohn DM; Teitcher JB; Mironov S; Iyer RB; Zhou Q; Iasonos A; Paul H; Hosaka M; Aghajanian CA; Leitao MM; Gardner GJ; Abu-Rustum NR; Sonoda Y; Levine DA; Hricak H; Chi DS
Gynecol Oncol; 2014 Sep; 134(3):455-61. PubMed ID: 25019568
[TBL] [Abstract][Full Text] [Related]
13. Total parietal peritonectomy with en bloc pelvic resection for advanced ovarian cancer with peritoneal carcinomatosis.
Kim HS; Bristow RE; Chang SJ
Gynecol Oncol; 2016 Dec; 143(3):688-689. PubMed ID: 27743737
[TBL] [Abstract][Full Text] [Related]
14. Computed tomography as a predictor of the extent of the disease and surgical outcomes in ovarian cancer.
Cerci ZC; Sakarya DK; Yetimalar MH; Bezircioglu I; Kasap B; Baser E; Yucel K
Ginekol Pol; 2016; 87(5):326-32. PubMed ID: 27304646
[TBL] [Abstract][Full Text] [Related]
15. Fusion imaging in preoperative assessment of extent of disease in patients with advanced ovarian cancer: feasibility and agreement with laparoscopic findings.
Moro F; Bertoldo V; Avesani G; Moruzzi MC; Mascilini F; Bolomini G; Caliolo G; Esposito R; Moroni R; Zannoni GF; Fagotti A; Manfredi R; Scambia G; Testa AC
Ultrasound Obstet Gynecol; 2021 Dec; 58(6):916-925. PubMed ID: 33847427
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted magnetic resonance imaging evaluation of intra-abdominal sites of implants to predict likelihood of suboptimal cytoreductive surgery in patients with ovarian carcinoma.
Espada M; Garcia-Flores JR; Jimenez M; Alvarez-Moreno E; De Haro M; Gonzalez-Cortijo L; Hernandez-Cortes G; Martinez-Vega V; Sainz De La Cuesta R
Eur Radiol; 2013 Sep; 23(9):2636-42. PubMed ID: 23604800
[TBL] [Abstract][Full Text] [Related]
17. Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.
Axtell AE; Lee MH; Bristow RE; Dowdy SC; Cliby WA; Raman S; Weaver JP; Gabbay M; Ngo M; Lentz S; Cass I; Li AJ; Karlan BY; Holschneider CH
J Clin Oncol; 2007 Feb; 25(4):384-9. PubMed ID: 17264334
[TBL] [Abstract][Full Text] [Related]
18. Preoperative ultrasound assessment of omental spread in ovarian cancer.
Conte M; Guariglia L; Benedetti Panici P; Scambia G; Matonti G; Mancuso S
Gynecol Obstet Invest; 1994; 38(3):213-6. PubMed ID: 8001879
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer.
Ricke J; Sehouli J; Hach C; Hänninen EL; Lichtenegger W; Felix R
Eur Radiol; 2003 May; 13(5):943-9. PubMed ID: 12695813
[TBL] [Abstract][Full Text] [Related]
20. Prospective validation of a laparoscopic predictive model for optimal cytoreduction in advanced ovarian carcinoma.
Fagotti A; Ferrandina G; Fanfani F; Garganese G; Vizzielli G; Carone V; Salerno MG; Scambia G
Am J Obstet Gynecol; 2008 Dec; 199(6):642.e1-6. PubMed ID: 18801470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
